Keloid lesions show increased IL-4/IL-13 signaling and respond to Th2-targeting dupilumab therapy. Article uri icon

Overview

publication date

  • December 19, 2019

Research

keywords

  • Antibodies, Monoclonal, Humanized
  • Keloid

Identity

Scopus Document Identifier

  • 85076758393

Digital Object Identifier (DOI)

  • 10.1111/jdv.16097

PubMed ID

  • 31747457

Additional Document Info

volume

  • 34

issue

  • 4